Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · January 05, 2021

Duodenal Mucosal Resurfacing Combined With GLP-1RA to Discontinue Insulin in Type 2 Diabetes

Gastrointestinal Endoscopy

 

Additional Info

Disclosure statements are available on the authors' profiles:

Gastrointestinal Endoscopy
Duodenal Mucosal Resurfacing Combined With GLP-1RA to Discontinue Insulin in Type 2 Diabetes: A Feasibility Study
Gastrointest. Endosc. 2020 Dec 23;[EPub Ahead of Print], ACG van Baar, S Meiring, P Smeele, T Vriend, F Holleman, M Barlag, N Mostafavi, JGP Tijssen, MR Soeters, M Nieuwdorp, JJGHM Bergman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading